SCHEMBL7369567

SCHEMBL7369567

CC(=O)NCCNc1ccccc1[N+](=O)[O-]

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.64
RAB9A P51151 4/20 0.64
MAPT P10636 5/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
KMT2A Q03164 2/20 0.63
LMNA P02545 2/20 0.63
GAA P10253 1/20 0.63
KAT2B Q92831 2/20 0.61
ALDH1A1 P00352 4/20 0.60
CA12 O43570 1/20 0.56
CA4 P22748 1/20 0.56
CA7 P43166 1/20 0.56
CA9 Q16790 1/20 0.56
CA14 Q9ULX7 1/20 0.56
HTT P42858 1/20 0.54
MEN1 O00255 1/20 0.54
RECQL P46063 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22162521 0.86 MAPT (0.56) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL2977328 0.86 RAB9A (0.65) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL2977331 0.86 RAB9A (0.65) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL6198859 0.85 KAT2B (0.80) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL8288907 0.81 RAB9A (0.60) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL29655446 0.81 NPC1 (0.59) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL2982740 0.81 NPC1 (0.59) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL12515298 0.81 KAT2B (0.69) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL906276 0.80 RECQL (0.51) NPC1RAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL906299 0.80 RECQL (0.54) NPC1RAB9AMAPTSMN1; SMN2KAT2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999026932-A1 BY AMIDINO GROUP SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTICOAGULANTS AXYS PHARMACEUTICALS, INC. (US) 1999-06-03 WO disclosed